SELECT MEDICAL HOLDINGS CORP (SEM) Fundamental Analysis & Valuation

NYSE:SEM • US81619Q1058

Current stock price

16.25 USD
-0.02 (-0.12%)
At close:
16.25 USD
0 (0%)
After Hours:

This SEM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. SEM Profitability Analysis

1.1 Basic Checks

  • SEM had positive earnings in the past year.
  • SEM had a positive operating cash flow in the past year.
  • Each year in the past 5 years SEM has been profitable.
  • Each year in the past 5 years SEM had a positive operating cash flow.
SEM Yearly Net Income VS EBIT VS OCF VS FCFSEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • The Return On Assets of SEM (2.44%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 8.38%, SEM is in the better half of the industry, outperforming 66.34% of the companies in the same industry.
  • SEM has a Return On Invested Capital (5.27%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for SEM is below the industry average of 8.94%.
  • The last Return On Invested Capital (5.27%) for SEM is above the 3 year average (4.28%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.44%
ROE 8.38%
ROIC 5.27%
ROA(3y)3.12%
ROA(5y)3.34%
ROE(3y)13.23%
ROE(5y)17.79%
ROIC(3y)4.28%
ROIC(5y)4.69%
SEM Yearly ROA, ROE, ROICSEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • SEM has a better Profit Margin (2.62%) than 65.35% of its industry peers.
  • In the last couple of years the Profit Margin of SEM has declined.
  • SEM has a Operating Margin of 6.17%. This is in the better half of the industry: SEM outperforms 69.31% of its industry peers.
  • SEM's Operating Margin has declined in the last couple of years.
  • SEM's Gross Margin of 11.54% is on the low side compared to the rest of the industry. SEM is outperformed by 71.29% of its industry peers.
  • In the last couple of years the Gross Margin of SEM has declined.
Industry RankSector Rank
OM 6.17%
PM (TTM) 2.62%
GM 11.54%
OM growth 3Y25.21%
OM growth 5Y-6.51%
PM growth 3Y-8.86%
PM growth 5Y-10.34%
GM growth 3Y9.83%
GM growth 5Y-4.91%
SEM Yearly Profit, Operating, Gross MarginsSEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. SEM Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SEM is destroying value.
  • SEM has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for SEM has been reduced compared to 5 years ago.
  • The debt/assets ratio for SEM is higher compared to a year ago.
SEM Yearly Shares OutstandingSEM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
SEM Yearly Total Debt VS Total AssetsSEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.62, we must say that SEM is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.62, SEM is in line with its industry, outperforming 44.55% of the companies in the same industry.
  • SEM has a debt to FCF ratio of 15.74. This is a negative value and a sign of low solvency as SEM would need 15.74 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 15.74, SEM is in line with its industry, outperforming 42.57% of the companies in the same industry.
  • A Debt/Equity ratio of 1.07 is on the high side and indicates that SEM has dependencies on debt financing.
  • SEM has a Debt to Equity ratio of 1.07. This is in the lower half of the industry: SEM underperforms 61.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 15.74
Altman-Z 1.62
ROIC/WACC0.63
WACC8.41%
SEM Yearly LT Debt VS Equity VS FCFSEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • SEM has a Current Ratio of 1.04. This is a normal value and indicates that SEM is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of SEM (1.04) is worse than 68.32% of its industry peers.
  • A Quick Ratio of 1.04 indicates that SEM should not have too much problems paying its short term obligations.
  • The Quick ratio of SEM (1.04) is worse than 60.40% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
SEM Yearly Current Assets VS Current LiabilitesSEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. SEM Growth Analysis

3.1 Past

  • The earnings per share for SEM have decreased strongly by -30.30% in the last year.
  • Measured over the past years, SEM shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.36% on average per year.
  • Looking at the last year, SEM shows a small growth in Revenue. The Revenue has grown by 5.12% in the last year.
  • The Revenue has been decreasing by -0.29% on average over the past years.
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
Revenue 1Y (TTM)5.12%
Revenue growth 3Y5.76%
Revenue growth 5Y-0.29%
Sales Q2Q%6.41%

3.2 Future

  • Based on estimates for the next years, SEM will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.12% on average per year.
  • Based on estimates for the next years, SEM will show a small growth in Revenue. The Revenue will grow by 4.76% on average per year.
EPS Next Y13.52%
EPS Next 2Y11.19%
EPS Next 3Y8.12%
EPS Next 5YN/A
Revenue Next Year5.04%
Revenue Next 2Y4.91%
Revenue Next 3Y4.76%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SEM Yearly Revenue VS EstimatesSEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
SEM Yearly EPS VS EstimatesSEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. SEM Valuation Analysis

4.1 Price/Earnings Ratio

  • SEM is valuated correctly with a Price/Earnings ratio of 14.13.
  • Based on the Price/Earnings ratio, SEM is valued cheaper than 82.18% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, SEM is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 12.45, which indicates a correct valuation of SEM.
  • Based on the Price/Forward Earnings ratio, SEM is valued cheaply inside the industry as 82.18% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.28, SEM is valued a bit cheaper.
Industry RankSector Rank
PE 14.13
Fwd PE 12.45
SEM Price Earnings VS Forward Price EarningsSEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • SEM's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SEM is cheaper than 78.22% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SEM indicates a somewhat cheap valuation: SEM is cheaper than 65.35% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.19
EV/EBITDA 8.02
SEM Per share dataSEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.05
PEG (5Y)N/A
EPS Next 2Y11.19%
EPS Next 3Y8.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. SEM Dividend Analysis

5.1 Amount

  • SEM has a Yearly Dividend Yield of 1.54%.
  • SEM's Dividend Yield is rather good when compared to the industry average which is at 0.50. SEM pays more dividend than 88.12% of the companies in the same industry.
  • SEM's Dividend Yield is comparable with the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 1.54%

5.2 History

  • SEM has been paying a dividend for at least 10 years, so it has a reliable track record.
  • SEM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
SEM Yearly Dividends per shareSEM Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • 21.99% of the earnings are spent on dividend by SEM. This is a low number and sustainable payout ratio.
DP21.99%
EPS Next 2Y11.19%
EPS Next 3Y8.12%
SEM Yearly Income VS Free CF VS DividendSEM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
SEM Dividend Payout.SEM Dividend Payout, showing the Payout Ratio.SEM Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SEM Fundamentals: All Metrics, Ratios and Statistics

SELECT MEDICAL HOLDINGS CORP

NYSE:SEM (3/20/2026, 8:22:22 PM)

After market: 16.25 0 (0%)

16.25

-0.02 (-0.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)04-29
Inst Owners82.51%
Inst Owner Change-3.76%
Ins Owners11.15%
Ins Owner Change0.41%
Market Cap2.02B
Revenue(TTM)5.45B
Net Income(TTM)142.92M
Analysts77.78
Price Target17.88 (10.03%)
Short Float %2.92%
Short Ratio1.79
Dividend
Industry RankSector Rank
Dividend Yield 1.54%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP21.99%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.41%
Min EPS beat(2)-31%
Max EPS beat(2)49.82%
EPS beat(4)2
Avg EPS beat(4)11.24%
Min EPS beat(4)-31%
Max EPS beat(4)49.82%
EPS beat(8)3
Avg EPS beat(8)-11.03%
EPS beat(12)7
Avg EPS beat(12)-1.92%
EPS beat(16)8
Avg EPS beat(16)-6.67%
Revenue beat(2)2
Avg Revenue beat(2)1.44%
Min Revenue beat(2)1.43%
Max Revenue beat(2)1.45%
Revenue beat(4)2
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)1.45%
Revenue beat(8)4
Avg Revenue beat(8)-1.37%
Revenue beat(12)8
Avg Revenue beat(12)-0.69%
Revenue beat(16)10
Avg Revenue beat(16)5.67%
PT rev (1m)-3.49%
PT rev (3m)-3.49%
EPS NQ rev (1m)5.09%
EPS NQ rev (3m)5.09%
EPS NY rev (1m)-1.4%
EPS NY rev (3m)-1.9%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)0.68%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE 14.13
Fwd PE 12.45
P/S 0.37
P/FCF 17.19
P/OCF 5.82
P/B 1.18
P/tB N/A
EV/EBITDA 8.02
EPS(TTM)1.15
EY7.08%
EPS(NY)1.31
Fwd EY8.03%
FCF(TTM)0.95
FCFY5.82%
OCF(TTM)2.79
OCFY17.19%
SpS43.97
BVpS13.75
TBVpS-6.1
PEG (NY)1.05
PEG (5Y)N/A
Graham Number18.86
Profitability
Industry RankSector Rank
ROA 2.44%
ROE 8.38%
ROCE 6.91%
ROIC 5.27%
ROICexc 5.3%
ROICexgc 10.74%
OM 6.17%
PM (TTM) 2.62%
GM 11.54%
FCFM 2.15%
ROA(3y)3.12%
ROA(5y)3.34%
ROE(3y)13.23%
ROE(5y)17.79%
ROIC(3y)4.28%
ROIC(5y)4.69%
ROICexc(3y)4.32%
ROICexc(5y)4.74%
ROICexgc(3y)8.45%
ROICexgc(5y)10.81%
ROCE(3y)5.62%
ROCE(5y)6.16%
ROICexgc growth 3Y36.24%
ROICexgc growth 5Y-11.26%
ROICexc growth 3Y45.51%
ROICexc growth 5Y-3.96%
OM growth 3Y25.21%
OM growth 5Y-6.51%
PM growth 3Y-8.86%
PM growth 5Y-10.34%
GM growth 3Y9.83%
GM growth 5Y-4.91%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 15.74
Debt/EBITDA 3.82
Cap/Depr 163.38%
Cap/Sales 4.2%
Interest Coverage 2.79
Cash Conversion 72.71%
Profit Quality 82.03%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 1.62
F-Score5
WACC8.41%
ROIC/WACC0.63
Cap/Depr(3y)127.38%
Cap/Depr(5y)112.75%
Cap/Sales(3y)4.41%
Cap/Sales(5y)4.06%
Profit Quality(3y)122.64%
Profit Quality(5y)96.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
EPS Next Y13.52%
EPS Next 2Y11.19%
EPS Next 3Y8.12%
EPS Next 5YN/A
Revenue 1Y (TTM)5.12%
Revenue growth 3Y5.76%
Revenue growth 5Y-0.29%
Sales Q2Q%6.41%
Revenue Next Year5.04%
Revenue Next 2Y4.91%
Revenue Next 3Y4.76%
Revenue Next 5YN/A
EBIT growth 1Y25.29%
EBIT growth 3Y32.43%
EBIT growth 5Y-6.78%
EBIT Next Year43.55%
EBIT Next 3Y18.69%
EBIT Next 5YN/A
FCF growth 1Y-60.35%
FCF growth 3Y7.47%
FCF growth 5Y-33.2%
OCF growth 1Y-33.1%
OCF growth 3Y6.75%
OCF growth 5Y-19.55%

SELECT MEDICAL HOLDINGS CORP / SEM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SELECT MEDICAL HOLDINGS CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SEM.


What is the valuation status for SEM stock?

ChartMill assigns a valuation rating of 5 / 10 to SELECT MEDICAL HOLDINGS CORP (SEM). This can be considered as Fairly Valued.


Can you provide the profitability details for SELECT MEDICAL HOLDINGS CORP?

SELECT MEDICAL HOLDINGS CORP (SEM) has a profitability rating of 5 / 10.


What are the PE and PB ratios of SELECT MEDICAL HOLDINGS CORP (SEM) stock?

The Price/Earnings (PE) ratio for SELECT MEDICAL HOLDINGS CORP (SEM) is 14.13 and the Price/Book (PB) ratio is 1.18.


Can you provide the financial health for SEM stock?

The financial health rating of SELECT MEDICAL HOLDINGS CORP (SEM) is 3 / 10.